219 related articles for article (PubMed ID: 1327841)
21. Electrophysiological and autoradiographical evidence for cholecystokinin A receptors on rat isolated nodose ganglia.
Widdop RE; Krstew E; Mercer LD; Carlberg M; Beart PM; Jarrott B
J Auton Nerv Syst; 1994; 46(1-2):65-73. PubMed ID: 8120343
[TBL] [Abstract][Full Text] [Related]
22. [3H]pBC 264, a suitable probe for studying cholecystokinin-B receptors: binding characteristics in rodent brains and comparison with [3H]SNF 8702.
Durieux C; Ruiz-Gayo M; Corringer PJ; Bergeron F; Ducos B; Roques BP
Mol Pharmacol; 1992 Jun; 41(6):1089-95. PubMed ID: 1614411
[TBL] [Abstract][Full Text] [Related]
23. Specific binding of D-Tyr25 (Nle28,31)-CCK(25-33) to cortical membranes from rat brain.
Carlberg M; Jarrott B; Beart PM
Neurosci Lett; 1991 Jan; 122(1):29-32. PubMed ID: 2057133
[TBL] [Abstract][Full Text] [Related]
24. CCKB receptor activation results in increased [3H]thymidine incorporation in rat glioma C6 cells.
Kaufmann R; Henklein P; Nowak G
Neuropeptides; 1995 Nov; 29(5):241-4. PubMed ID: 8587658
[TBL] [Abstract][Full Text] [Related]
25. Evidence for cholecystokininA receptors in bovine adrenal chromaffin cells.
Aarnisalo AM; Vainio PJ; Männistö PT; Vasar E; Tuominen RK
Neuroreport; 1996 Sep; 7(13):2167-70. PubMed ID: 8930982
[TBL] [Abstract][Full Text] [Related]
26. N-methylated analogs of Ac[Nle28,31]CCK(26-33): synthesis, activity, and receptor selectivity.
Ron D; Gilon C; Hanani M; Vromen A; Selinger Z; Chorev M
J Med Chem; 1992 Jul; 35(15):2806-11. PubMed ID: 1495013
[TBL] [Abstract][Full Text] [Related]
27. CCK-8-stimulated insulin secretion in vivo is mediated by CCKA receptors.
Karlsson S; Ahrén B
Eur J Pharmacol; 1992 Mar; 213(1):145-6. PubMed ID: 1499651
[TBL] [Abstract][Full Text] [Related]
28. Cholecystokinin-GABA interactions in rodent cortex: analyses of cholecystokinin effects on K(+)- and L-glutamate-induced release of [3H]GABA from rat cortical slices and cultured mouse cortical neurones.
Hickling YM; Cheung NS; Larm JA; Cowen MS; Shulkes A; Beart PM
Neurochem Int; 1997 Feb; 30(2):171-9. PubMed ID: 9017664
[TBL] [Abstract][Full Text] [Related]
29. Full and partial agonist activity of C-terminal cholecystokinin peptides at the cloned human CCK-A receptor expressed in Chinese hamster ovary cells.
Dunlop J; Zhang Y; Evans N
Peptides; 1997; 18(6):865-8. PubMed ID: 9285936
[TBL] [Abstract][Full Text] [Related]
30. Role of substance P in the regulation of ion transport by CCKA and CCKB receptors in mouse ileum.
Rao RK; Levenson S; Fang SN; Hruby VJ; Yamamura HI; Porreca F
Ann N Y Acad Sci; 1994 Mar; 713():420-1. PubMed ID: 7514373
[No Abstract] [Full Text] [Related]
31. Structure-based design of new constrained cyclic agonists of the cholecystokinin CCK-B receptor.
Blommaert AG; Dhôtel H; Ducos B; Durieux C; Goudreau N; Bado A; Garbay C; Roques BP
J Med Chem; 1997 Feb; 40(5):647-58. PubMed ID: 9057851
[TBL] [Abstract][Full Text] [Related]
32. Gastrin13 and the C-terminal octapeptide of cholecystokinin are differently coupled to G-proteins in guinea-pig brain membranes.
Lallement JC; Galleyrand JC; Lima-Leite AC; Fulcrand P; Martinez J
Eur J Pharmacol; 1994 May; 267(3):297-305. PubMed ID: 8088368
[TBL] [Abstract][Full Text] [Related]
33. Benzodiazepine analogues L365,260 and L364,718 as gastrin and pancreatic CCK receptor antagonists.
Huang SC; Zhang L; Chiang HC; Wank SA; Maton PN; Gardner JD; Jensen RT
Am J Physiol; 1989 Jul; 257(1 Pt 1):G169-74. PubMed ID: 2473653
[TBL] [Abstract][Full Text] [Related]
34. Development of CCK-tetrapeptide analogues as potent and selective CCK-A receptor agonists.
Shiosaki K; Lin CW; Kopecka H; Craig R; Wagenaar FL; Bianchi B; Miller T; Witte D; Nadzan AM
J Med Chem; 1990 Nov; 33(11):2950-2. PubMed ID: 1700123
[No Abstract] [Full Text] [Related]
35. In vivo binding affinities of cholecystokinin agonists and antagonists determined using the selective CCKB agonist [3H]pBC 264.
Durieux C; Ruiz-Gayo M; Roques BP
Eur J Pharmacol; 1991 Dec; 209(3):185-93. PubMed ID: 1797561
[TBL] [Abstract][Full Text] [Related]
36. Combined dose-ratio analysis of cholecystokinin receptor antagonists, devazepide, lorglumide and loxiglumide in the guinea-pig gall bladder.
Bishop LA; Gerskowitch VP; Hull RA; Shankley NP; Black JW
Br J Pharmacol; 1992 May; 106(1):61-6. PubMed ID: 1504732
[TBL] [Abstract][Full Text] [Related]
37. CCKA receptors mediate slow depolarizations in cultured mammalian sympathetic neurons.
Knoper SR; Meehan AG; Purnyn S; Coggan JS; Anthony TL; Kreulen DL
Eur J Pharmacol; 1993 Feb; 232(1):65-9. PubMed ID: 8458396
[TBL] [Abstract][Full Text] [Related]
38. CholecystokininA and cholecystokininB receptors in neurons of the brainstem solitary complex of the rat: pharmacological identification.
Branchereau P; Böhme GA; Champagnat J; Morin-Surun MP; Durieux C; Blanchard JC; Roques BP; Denavit-Saubié M
J Pharmacol Exp Ther; 1992 Mar; 260(3):1433-40. PubMed ID: 1545402
[TBL] [Abstract][Full Text] [Related]
39. "Gastrin" and "CCK" receptors on histamine- and somatostatin-containing cells from rabbit fundic mucosa-II. Characterization by means of selective antagonists (L-364,718 and L-365,260).
Roche S; Gusdinar T; Bali JP; Magous R
Biochem Pharmacol; 1991 Jul; 42(4):771-6. PubMed ID: 1714276
[TBL] [Abstract][Full Text] [Related]
40. Changes in motor activity and forebrain [propionyl-3H]propionylated-CCK-8 binding in mice after repeated administration of drugs affecting cholecystokinin receptors.
Vasar E; Stephenson JD; Meldrum BS
Eur J Pharmacol; 1991 Sep; 202(3):385-90. PubMed ID: 1748160
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
